Pfizer CEO criticizes Clinton drug plan

On Thursday, Pfizer Inc. (NYSE:PFE) Chairman and CEO Ian Read said Hillary Clinton's proposals for controlling prescription drug costs would be "very negative for innovation."

At the Wells Fargo Healthcare Conference in Boston, he said Clinton's approach to healthcare "drives you to a one-payer system, drives you to rationing, drives you to a place where most consumers don't want to be." Read predicted the U.S. will not adopt drug price controls and that changes in U.S. drug pricing policy will be enacted as part of reforms to the health exchanges created by the Affordable Care Act. ...